封面
市场调查报告书
商品编码
1438479

穿戴式机器人和外骨骼:市场占有率分析、行业趋势和统计、成长预测(2024-2029)

Wearable Robots and Exoskeletons - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

穿戴式机器人和外骨骼市场规模预计到 2024 年为 25.5 亿美元,在预测期内(2024-2029 年)预计到 2029 年将达到 102.5 亿美元,复合年增长率为 32.05%。

穿戴式机器人和外骨骼 - 市场

由于Covid-19感染疾病的出现以及迄今为止各地实施的封锁措施,机器人供应商在短时间内陷入完全停滞。然而,另一方面,疫情对产品和服务提供者提出了挑战,要求他们透过与临床医生和行业合作伙伴合作、应对不断变化的卫生服务并主要关注现实世界的临床挑战来行销其产品和服务。存在增加的行业机会。患者的需求。

主要亮点

  • 穿戴式机器人或外骨骼正处于发展的早期阶段,这些可穿戴外骨骼辅助个体运动,可以附着在人体上并由人体控制,使其在医疗保健、工业、军事、它不断发展以代表最新的采用。它也有助于人们的运动。
  • 在医疗保健领域,外骨骼透过协助和促进直立行走和重新学习失去的功能来帮助中风患者和瘫痪患者康復。根据 Maxon Motor AG 的研究,该公司估计全球约有 1.85 亿人每天使用轮椅。
  • 例如,Ekso GT是Esko Bionics公司的一款外骨骼,是一款穿戴式外骨骼,设计为综合步态治疗工具,为患者和治疗师提供无与伦比的復健体验。此外,科技的进步使得法国一名瘫痪男子开始使用意念控制外骨骼行走。
  • 业内多家公司已经测试了他们的外骨骼製造能力并准备部署它们,未来市场可能会进一步扩大。例如,汽车製造商福特选择了 EksoVest,计划在全球 15 个组装厂部署外骨骼。这种外骨骼可以举起并支撑执行重复性头顶任务的工人的手臂。 EksoVest 在试用期间将职场减少了 83%。
  • 对帮助个人移动的外骨骼的需求也在增加。患有帕金森氏症和中风等身体运动障碍的患者数量不断增加,是加速外骨骼需求的主要因素。这是因为这些疾病限制了自主身体运动并导致日常生活活动出现问题。例如,帕金森氏症基金会估计,2020年美国帕金森氏症患者人数可能约93万人,预计2030年将达到120万人。

穿戴式机器人和外骨骼市场趋势

医疗保健预计将占据很大份额

  • 外骨骼在医疗产业的应用越来越多,从物理治疗到紧急服务。例如,总部位于德里的新兴企业GenElek Technologies 提供机器人辅助系统,帮助患有中风、瘫痪、脊髓损伤 (SCI) 或其他神经系统疾病的人。外骨骼帮助残障人士重新行走。它帮助他们变得独立和自力更生,对他们的身心都有好处。上述这些进步预计将推动医疗保健市场的发展。
  • 印度康復委员会的一份报告显示,印度每年有超过 15,000 人因脊髓损伤或中风而失去行走能力,这意味着每年每百万人中有 15 名新感染者。当地公司提供外戴机器人和增强人类边缘系统能力的外骨骼支撑系统。
  • 此外,市场上的许多参与者都在不断努力创新其产品,并获得医疗保健行业人士的必要核准。例如,为下肢残障人士提供机器人医疗设备的製造商ReWalk Robotics宣布,美国食品药物管理局已批准该公司向美国康復中心出售其ReStore软外装系统。
  • 此外,一些规模较小的公司正在兴起。例如,日本的 Archelis Inc. 展示了其 ArchelisFX 外骨骼,该外骨骼源自日语,意为「方便行走的椅子」。该设备的设计考虑了多种场景,包括背痛或最近接受手术的人。该公司表示,可以以约 5,000 美元的价格租用或购买。
  • 2021年1月,总部位于加州的外骨骼技术创新者suitX宣布推出其新型穿戴式外骨骼ShieldX。专为需要穿着厚防辐射围裙的医护人员而设计。 ShieldX将沉重的防辐射围裙对使用者肩膀和脊椎的重量减轻了100%。 ShieldX 旨在减少与这些重型围裙相关的颈部和背部伤害,这些伤害会缩短职业生涯并限制非工作活动。

亚太地区预计将占据最大市场占有率

  • 亚太地区是穿戴式机器人技术研发的领导者。尤其是韩国和日本,在研发方面处于市场领先地位。例如,2021年4月,韩国机械材料研究院的调查团队开发了可穿戴机器人技术,这是一种西装形状的可穿戴设备,可用于从送货到建筑工作等各种物理任务。附着在手臂和大腿等身体部位以支撑肌肉。
  • 韩国一直是机器人和自动化技术的製造中心。注重研发和政府在创新技术上的支出是该国穿戴式机器人技术进步的关键因素。该国的私营部门也在积极扩大与穿戴式机器人和外骨骼相关的技术和应用范围。
  • 例如,三星电子于2021年6月宣布,将于年终将用于医疗保健的穿戴式机器人商业化。这家韩国科技巨头正在进入机器人领域,将其作为其主要成长动力之一。该公司表示,计划推出一款穿戴式机器人,可以帮助站立、行走或跑步有困难的用户,也可以用作健身设备。这款穿戴式机器人的价格预计在500万韩元至1,000万韩元之间,但该公司可能会降低价格,使其更实惠。
  • 穿戴式机器人和外骨骼市场的参与者正在增加在亚太地区的投资。例如,2021年4月,总部位于香港的外骨骼市场产业领导者Ekso Bionics宣布与澳洲皇家復健中心合作,进一步扩大其机器人外骨骼在亚太地区的使用。
  • 该地区的军队也在开发军用外骨骼机器人。例如,2021年10月,台湾推出了第一代电池供电的外骨骼套装,可以提高士兵的身体耐力,并增加他们在各种军事行动中的机动性。

穿戴式机器人及外骨骼产业概况

由于 Cyber​​dyne Inc.、ReWalk Robotics Inc. 和 Ekso Bionics Holdings Inc. 等主要参与者的存在,可穿戴机器人和外骨骼市场本质上竞争激烈。此外,市场潜力导致许多Start-Ups投资该市场,加剧了竞争。许多公司透过推出新产品、扩大业务或策略併购来扩大市场占有率。

  • 2021年7月,Cyber​​dyne Co., Ltd.与J-Workout Co., Ltd.(东京江东区,总裁兼首席执行官:Takunori Isa,以下简称“J-Workout”)建立了业务,并从 2021 年 8 月起,我们将提供以下新服务。 Neuro HALFIT 是一种透过使用穿戴式半机械人 HAL 活化大脑神经系统活动循环来促进运动功能下降患者功能改善的服务。
  • 2021 年 3 月 - Ekso Bionics 宣布与美国的物理治疗师建立合作关係,向医生宣传 EksoNR 外骨骼的临床益处。此次合作将有助于提高医生和其他復健治疗师对 Ekso Bionics 技术的认识,并教导他们如何成功地将机器人技术融入復健计画中。

其他福利

  • Excel 格式的市场预测 (ME) 表
  • 3 个月分析师支持

目录

第一章 简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场洞察

  • 市场概况
  • 产业吸引力-波特五力分析
    • 新进入者的威胁
    • 买方议价能力
    • 供应商的议价能力
    • 替代威胁
    • 竞争公司之间敌对的强度
  • 评估感染疾病-19 对产业的影响

第五章市场动态

  • 市场驱动因素
    • 医疗保健产业对机器人復健的需求不断增加
    • 加大外骨骼技术研发投入
  • 市场限制因素
    • 设备成本高

第六章市场区隔

  • 按类型
    • 动力外骨骼
    • 被动外骨骼
  • 按最终用户产业
    • 卫生保健
    • 军事和国防
    • 产业
    • 其他最终用户产业
  • 按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 世界其他地区

第七章 竞争形势

  • 公司简介
    • Cyberdyne Inc.
    • ReWalk Robotics Inc.
    • Ekso Bionics Holdings Inc.
    • Sarcos Corporation
    • Honda Motor Co. Ltd.
    • Hocoma AG(DIH International Ltd.)
    • Lockheed Martin Corporation
    • Technaid. SL
    • Skelex
    • ATOUN Inc.

第八章投资分析

第9章市场的未来

简介目录
Product Code: 67219

The Wearable Robots and Exoskeletons Market size is estimated at USD 2.55 billion in 2024, and is expected to reach USD 10.25 billion by 2029, growing at a CAGR of 32.05% during the forecast period (2024-2029).

Wearable Robots and Exoskeletons - Market

Due to the emergence of the COVID-19 pandemic, the previously put lockdown measures across various regions significantly brought the robotic suppliers to a complete standstill for a short period. However, on the other hand, the pandemic has also created productive industry opportunities for the products and service providers to increase their presence in the market by primarily focusing on and addressing real clinical challenges in collaboration with clinicians and industry partners and in response to the evolving patients' needs.

Key Highlights

  • The wearable robots or exoskeletons are in their nascent stage of development and continuously evolving to exhibit maximum adoption in various industries, like healthcare, industrial, military, and defense, as these wearable exoskeletons assist personal mobility and can be worn on the human body and control and assists the movements of the person.
  • In the healthcare sector, exoskeletons are helping patients' recovery by assisting and encouraging upright walking and relearning lost functions for stroke patients and people who are paralyzed. According to a study by Maxon Motor AG, the company estimated that approximately 185 million people use a wheelchair daily worldwide.
  • For instance, Ekso GT is an exoskeleton by Esko Bionics, which is a wearable exoskeleton engineered as a comprehensive gait therapy tool and provides an unparalleled rehabilitation experience for patients and therapists. Additionally, due to technological developments in technology, a paralyzed man started walking using a mind-controlled exoskeleton in France.
  • Various companies in the industry have already tested exoskeletons for their manufacturing capabilities and are ready to deploy them, which is likely to augment the market in the future further. For instance, automobile manufacturer, Ford, planned to deploy exoskeletons in fifteen assembly plants worldwide and adopted the EksoVest. This exoskeleton elevates and supports the arms of workers performing repeated overhead tasks. The adoption of EksoVests reduced workplace injuries by 83% during the trial period.
  • There is also an increasing demand for exoskeletons to assist in personal mobility. An increasing number of patients with body movement disorders, such as Parkinson's disease, strokes, etc., are the prime factors accelerating the exoskeleton demand, as these diseases limit voluntary body movements and create problems in daily routine activities. For instance, according to the Parkinson's Foundation estimates, the number of people in the United States with Parkinson's disease may be around 930,000 in 2020, and it is expected to reach 1,200,000 by 2030.

Wearable Robots & Exoskeletons Market Trends

Healthcare is Expected to Hold a Significant Share

  • Exoskeletons have increasing applications in medical industries ranging from physiotherapy to emergency services. For example, GenElek Technologies, a Delhi-based startup, provides a robotic support system that aids people suffering from stroke, paralysis, spinal cord injury (SCI), or other neurological conditions. The exoskeleton assists disabled people in walking again. It will help them become self-reliant and independent, which will benefit them physically and mentally. These advancements mentioned above are expected to drive the healthcare market.
  • According to a report of the Rehabilitation Council of India, every year, more than 15,000 people lose their ability to walk either due to a spinal injury or stroke in India, which translates to 15 new cases per million every year, which provides an opportunity for local companies to provide an externally worn robotic and exoskeleton support system that enhances a human's limbic capabilities.
  • Further, many players in the market are constantly trying to innovate products for people in the Healthcare industry and get the necessary approval. For instance, ReWalk Robotics, a manufacturer of robotic medical devices for individuals with lower limb disabilities, announced that the US Food and Drug Administration had cleared its ReStore soft exo-suit system for sale to rehabilitation centers across the United States.
  • Moreover, some smaller companies have also emerged. For instance, Japan-based Archelis Inc. showcased the ArchelisFX exoskeleton, which derives from the Japanese word for "walkable chair." The device is designed for several scenarios, including back pain and recently undergoing surgery. The company said it would be available to rent or buy for around USD 5,000.
  • In January 2021, suitX, a California-based innovator in exoskeleton technologies, announced the launch of a novel wearable exoskeleton, shieldX. It is made for the healthcare personnel required to wear heavy anti-radiation aprons. ShieldX removes 100% of the weight of a heavy anti-radiation apron from the user's shoulders and spine. ShieldX aims to reduce neck and back injuries linked to these heavy aprons shortening careers and limiting activities outside of work.

Asia Pacific is Expected to Account for the Largest Market Share

  • Asia-Pacific is the leader in the R&D of wearable robot technology. South Korea and Japan are specifically leading in the R&D of the market. For instance, in April 2021, a South Korean research team from the Korea Institute of Machinery and Materials developed a wearable robot technology, a suit-type wearable device, that can be used for a variety of physical tasks from delivery to construction work. It can be attached to the arm, thigh, and other body areas for supporting muscles.
  • South Korea has always been the hub for the manufacture of robotics and automation technologies. The focus on R&D and government expenditure on innovative technologies were significant factors for the advancement of wearable robotics in the country. The private sector of the country is also actively expanding its technologies and applications range related to wearable robots and exoskeletons.
  • For instance, in June 2021, Samsung Electronics Co. announced to commercialize of a wearable robot for healthcare by the end of 2021. This South Korean tech giant is delving into the robotics sector as one of its major growth drivers. According to the company, it has plans to introduce a wearable robot that helps users that have trouble standing up, walking, or running and can also be used as a fitness device. This wearable robot is expected to be priced between KRW 5 million and KRW 10 million, but the company may bring the price down to make it more affordable.
  • Wearable robots and exoskeleton market players are increasingly investing in the Asia-Pacific region. For instance, in April 2021, Ekso Bionics, an industry leader in the exoskeleton market with a presence in Hong Kong, announced a partnership with Royal Rehab in Australia, further expanding the use of the company's robotic exoskeleton across Asia-Pacific.
  • Militaries in the region are also developing exoskeleton robots for their troops. For instance, in October 2021, Taiwan launched the first generation of a battery-powered exoskeleton suit that can improve the physical endurance of soldiers and increase mobility in various military operations.

Wearable Robots & Exoskeletons Industry Overview

The Wearable Robots and Exoskeletons Market is competitive in nature because of the presence of major players like Cyberdyne Inc., ReWalk Robotics Inc., and Ekso Bionics Holdings Inc., among others. Further, the market potential is also attracting many startups investing in the market, thus, intensifying the competition. Many companies increase their market presence by introducing new products, expanding their operations, or entering into strategic mergers and acquisitions.

  • July 2021 - Cyberdyne Inc has formed a business alliance with J-Workout Inc. (Koto-Ku, Tokyo, Japan, President: Takunori Isa, "J-Workout") to provide a new service stated below from August 2021. The Group provides Neuro HALFIT as a service to promote the functional improvement of people with reduced motor functions by activating the activity loop of the brain's nervous system with Wearable Cyborg HAL.
  • March 2021 - Ekso Bionics announced a partnership with the US Physiatry to educate physicians on the clinical benefits of an EksoNR exoskeleton. The partnership will help raise awareness of Ekso Bionics technology among physicians and other rehabilitation therapists and teach them how to integrate robotics into rehabilitation programs successfully.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Threat of New Entrants
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Bargaining Power of Suppliers
    • 4.2.4 Threat of Substitute
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Assessment of the COVID-19 Impact on the Industry

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Increasing Demand for Robotic Rehabilitation in Healthcare Industry
    • 5.1.2 Growing Investment in the Development of the Exoskeleton Technology
  • 5.2 Market Restraints
    • 5.2.1 High Cost of the Equipment

6 MARKET SEGMENTATION

  • 6.1 By Type
    • 6.1.1 Powered Exoskeletons
    • 6.1.2 Passive Exoskeletons
  • 6.2 By End-user Industry
    • 6.2.1 Healthcare
    • 6.2.2 Military and Defense
    • 6.2.3 Industrial
    • 6.2.4 Other End-user Industries
  • 6.3 By Geography
    • 6.3.1 North America
    • 6.3.2 Europe
    • 6.3.3 Asia Pacific
    • 6.3.4 Rest of the World

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Cyberdyne Inc.
    • 7.1.2 ReWalk Robotics Inc.
    • 7.1.3 Ekso Bionics Holdings Inc.
    • 7.1.4 Sarcos Corporation
    • 7.1.5 Honda Motor Co. Ltd.
    • 7.1.6 Hocoma AG (DIH International Ltd.)
    • 7.1.7 Lockheed Martin Corporation
    • 7.1.8 Technaid. S.L.
    • 7.1.9 Skelex
    • 7.1.10 ATOUN Inc.

8 INVESTMENT ANALYSIS

9 FUTURE OF THE MARKET